DNA changes in Alzheimer's disease: What they mean to patients, families

by Mayo Clinic

edited by Sadie Harley, reviewed by Andrew Zinin

Sadie Harley

Scientific Editor

Meet our editorial team
Behind our editorial process

Andrew Zinin

Chief Editor

Meet our editorial team
Behind our editorial process Editors' notes

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

trusted source

proofread

The GIST Add to Preferred Sources

Scientists know that age is the greatest risk factor for Alzheimer's disease, but aging alone doesn't explain why some people develop the condition while others do not. Genetics, lifestyle factors and environmental influences also appear to play a role. Researchers are working to understand how these factors interact in the brain, explains Nilüfer Ertekin-Taner, M.D., Ph.D., a neurologist and neuroscience chair at Mayo Clinic in Florida.

Alzheimer's disease is the most common cause of dementia. It affects memory, thinking, behavior and the ability to carry out everyday activities.

"For many years, Alzheimer's research has focused on two proteins found in the brain: amyloid and tau. The buildup of these proteins is one of the best-known features of the disease," Ertekin-Taner says. "While these proteins remain important, researchers now recognize that Alzheimer's is a complex disease involving many biological processes beyond amyloid and tau."

A recent Mayo Clinic study explored another piece of the puzzle: changes in how the brain turns genes on and off.

Genes are sections of DNA that provide instructions for how cells work. Cells can control which genes are active and which remain inactive, allowing them to carry out different functions without changing the underlying DNA sequence. Scientists call this process epigenetics. These chemical changes can influence how cells behave and respond to aging, disease and environmental factors.

In the study, researchers examined brain tissue from hundreds of people with Alzheimer's disease and looked for patterns in these gene-regulating changes. They identified several changes strongly linked to the tau protein.

The research also highlighted the possible importance of oligodendrocytes—brain cells that support nerve cells by producing myelin, a protective layer that helps signals move efficiently. When myelin is damaged, communication in the brain may be disrupted.

"The findings suggest that Alzheimer's disease may involve not only damage to nerve cells but also changes in the systems that support how those cells communicate with one another," explains Ertekin-Taner, the study's senior author. "This growing understanding is encouraging researchers to look beyond traditional explanations of the disease."

So, what does this mean for patients today?

These findings are not expected to change how Alzheimer's disease is diagnosed or treated right now, Ertekin-Taner says. Scientists must confirm the findings, better understand how these changes affect the brain and determine whether the discoveries can lead to safe and effective treatments.

"One reason researchers are excited about epigenetics is that, unlike inherited DNA changes, some gene-control changes may be reversible," she adds. "While much more research is needed, the findings so far suggest that future therapies could target these biological processes."

Studies like this also help identify new areas for investigation and may reveal why Alzheimer's disease affects people differently, Ertekin-Taner says. As researchers learn more, they move closer to developing more personalized approaches to prevention and treatment.

The Mayo Clinic team that did research on the DNA changes associated with the disease also created a free online tool that allows researchers worldwide to explore the study's data. Called the Multiomic Atlas of AD Brain Endophenotypes, the searchable resource lets scientists look up specific genes and view results in interactive tables and graphs.

By making these findings widely available, researchers hope to accelerate discoveries and support the development of improved treatments for Alzheimer's disease and other neurological conditions.

Key medical concepts

Alzheimer's DiseaseProcess, Epigenetictau ProteinsOligodendroglia

Clinical categories

NeurologyClinical geneticsCommon illnesses & PreventionHealthy aging Provided by Mayo Clinic Who's behind this story?

Sadie Harley

BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →

Andrew Zinin

Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →

Citation: DNA changes in Alzheimer's disease: What they mean to patients, families (2026, October 12) retrieved 12 October 2026 from https://medicalxpress.com/news/2026-10-dna-alzheimer-disease-patients-families.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.